chrisvoncsefalvay/vaers-outcomes huggingface dataset:
She received J&J dose 2 on 11/18/21. 11/23/21 she developed right hearing loss and ear fullness. Fever, headache, and brainfog, "felt like walking on a cloud". Feverish feeling ongoing without objective fever, brainfog continues, and still has a headache and hearing loss in right ear.
Subsequent to receiving two doses of varicella virus vaccine live in 1996, the pt was seen by his physician for a moderate case of chickenpox. Pt had vesicles on his trunk and extremities. The vesicles were described as only mildly itchy. In addition the pt had a mild fever and malaise. Follow up states scab formation was noted by 03/13/2000.
I developed a really bad Dermatographia; Just a slight scratch like someone wrote in my arms all the time; Sometimes its really itchy; Even my face its really red from head to toes/when I wash my hand with hot or cold water it turns red; This spontaneous case was reported by a consumer and describes the occurrence of MECHANICAL URTICARIA (I developed a really bad Dermatographia), SCRATCH (Just a slight scratch like someone wrote in my arms all the time), PRURITUS (Sometimes its really itchy) and ERYTHEMA (Even my face its really red from head to toes/when I wash my hand with hot or cold water it turns red) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 025O20A) for COVID-19 vaccination.     Concomitant products included CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.   On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Jan-2021, the patient experienced MECHANICAL URTICARIA (I developed a really bad Dermatographia), SCRATCH (Just a slight scratch like someone wrote in my arms all the time), PRURITUS (Sometimes its really itchy) and ERYTHEMA (Even my face its really red from head to toes/when I wash my hand with hot or cold water it turns red). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for Allergy, at a dose of UNK, bid and LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) for Allergy, at a dose of UNK, bid. At the time of the report, MECHANICAL URTICARIA (I developed a really bad Dermatographia), SCRATCH (Just a slight scratch like someone wrote in my arms all the time), PRURITUS (Sometimes its really itchy) and ERYTHEMA (Even my face its really red from head to toes/when I wash my hand with hot or cold water it turns red) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No medical history was provided by reporter. Concomitant medicine include Vitamin D Treatment Took Zyrtec, Benadryl or Claritin  but still doesn't help
This spontaneous report as received from a medical assistant, referring to a 18 year old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 12-JUL-2017, the patient was vaccinated with the adult dose of VAQTA lot number N005605 with expiration date on 08-APR-2018, 1 ml (strength, anatomical location and administration route were not reported) for prophylaxis. No adverse effects were reported. No further information was provided.
Patient recieved 3 vaccines-Hep A and Menactra given at the same time-followed by Gardasil.  Patient stated she felt dizzy and then when we went to lay her down from a sitting position she passed out.
This case was reported by a nurse and described the occurrence of multiple sclerosis symptoms in a female subject of unspecified age who was vaccinated with hepatitis B vaccine recombinant (Engerix-B) for prophylaxis. On 24 October 2005, the subject received the 1st dose of Engerix-B (lot AHBVB076BA). On 24 October 2005, the subject also received live attenuated MMR II (strain not specified). On 02 December 2005 the subject received 2nd dose of Engerix-B (lot AHBVB172AA). On an unspecified date on or after 02 December 2005 and or before 04 May 2006, less than one year after vaccination with Engerix-B, the subject experienced multiple sclerosis like symptoms. The outcome of the event was not reported. Comment: Multiple sclerosis symptoms was assessed as medically serious.
Swollen area at site of injection 4 " Diameter,  hot to touch, painful, ache in joints of arm , elbow, wrist.
stroke; This is a spontaneous report received from contactable reporter(s) (Physician) from a sales representative. The reporter is the patient.  A 78-year-old male patient received BNT162b2 (COMIRNATY), in 2021 as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, manufacturer unknown), administration date: 2021, for COVID-19 IMMUNIZATION. The following information was reported: CEREBROVASCULAR ACCIDENT (medically significant), 3 months after the suspect product(s) administration, outcome "unknown", described as "stroke". The patient experienced a stroke and otherwise was healthy and active, and still practicing medicine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on the temporal relation, the association between the event of cerebrovascular accident and the suspect product cannot be completely ruled out.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
p/vax & p/leaving office, child did not nurse well;failed to wake up & did not nurse well for next feed;advised to come to ER-noted by ER to be lethargic;sepsis workup negative;sx now resolved;no fever;
shortness of breath, dizziness, migraine, nausea, diarrhea, hives, itching, blurry and visual disturbances, body aches, cramps, severe fatigue  day 2 facial swelling  left side of face cold pins and needles and tingling left side of tongue felt swollen and numb slurred speech lasting 10-15 min
L arm mild cellulitis - 1" x 1 1/2" marked, tender erythematous, indurated.
Initial Report Received: 27-Feb-2019. Non-significant Follow-up Report Received on 06-Mar-2019 included duplicative data that was already received for this report. A nurse reported that patient, a 69-year-old female patient (race not provided) was administered with HEPLISAV-B for hepatitis B immunization that was reported to be stored at the wrong temperature. Relevant medical history and concomitant medications were reported as unknown. Allergies were reported as unknown. On an unknown date, the patient received the second injection of HEPLISAV-B (lot #1036463, expiration date 28-Jul-2019, NDC #43528-002-05) by a physician. On 27-Feb-2019, a nurse reported that she received a call from a customer service representative at the distributor, on this day. The nurse was instructed to remove all vaccines that were received because they were stored at the wrong temperature on distributor's end. The nurse was instructed to return it to the distributor and contact Dynavax. The nurse reported that six patients received HEPLISAV-B from the same lot number. The nurse also reported that all six patients were contacted on this day. No adverse events were reported. The reporter did not provide a seriousness assessment for the event. Company comment: The company assessed the event of product storage error as non-serious. The event of product storage error is unlisted per HEPLISAV-B USPI. Sender's Comments: The company assessed the event of product storage error as non-serious. The event of product storage error is unlisted per HEPLISAV-B USPI.
Herpes zoster reactivation shortly after administration of a mRNA vaccine; This is a literature report.  A 34 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1,single for covid-19 immunisation. Relevant medical history included: "eczema" (unspecified if ongoing); "skin rash" (unspecified if ongoing); "pseudodendritic lesions" (unspecified if ongoing). The patient's concomitant medications were not reported.  The following information was reported: OPHTHALMIC HERPES ZOSTER (medically significant), outcome "unknown", described as "Herpes zoster reactivation shortly after administration of a mRNA vaccine". The patient underwent the following laboratory tests and procedures: investigation: she was noted to have a typical v1 rash of herpes, notes: zoster with a marginal upper lid lesion as well. Therapeutic measures were taken as a result of ophthalmic herpes zoster.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on the information in the case report, a causal association between reported event ophthalmic herpes zoster and BNT162B2 cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : PFIZER INC-202200174900 Same article/drug/event and different patient; PFIZER INC-202200206630 Same article/drug/event and different patient; PFIZER INC-202200206630 Same article/drug/event and different patient
mild ache in the muscle of my arm which lasted a few days before the ache disappeared; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), in Sep2021 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Vaxzevria (Dose: 1, batch No: 000074A), administration date: Feb2021, for Covid-19 immunization, reaction(s): "mild ache in the muscle of my arm which lasted a few days before the ache disappeared"; Vaxzevria (Dose: 2), administration date: Apr2021, for Covid-19 immunization, reaction(s): "mild ache in the muscle of my arm which lasted a few days before the ache disappeared". The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "mild ache in the muscle of my arm which lasted a few days before the ache disappeared".   Additional information: On 01Mar2022 patient had the Moderna vaccine [batch no 000074a]. The Moderna jab was my 4th vaccine [booster]. The previous being two Astrazeneca in Feb2021 & Apr2021 and a pfizer at the end of Sep2021. Each vaccine produce a mild ache in the muscle of my arm which lasted a few days before the ache disappeared. since the moderna jab of 1st march the ache has not gone away. the ache is noticeable all the time [ on a pain scale of 1 - 10 around a 3] i now find that mobility in my arm can cause more pain in certain positions i.e. if i have been sleeping on it or trying to lift arm above shoulder level or showering. [pain level of 1 - 10 around an 8] the reason i an writing is to enquire if you know of other people who have had / do have similar ? I am a (withheld) Aged Yours ()  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Covid-19 positive; This is a spontaneous report from a Pfizer-sponsored program. A contactable unspecified age of female consumer reported for herself that she received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), via an unspecified route of administration on 06Feb2021 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On 11Feb2021, the patient experienced covid-19 positive. The outcome of the event was unknown.  Information on the Lot/Batch number has been requested.
9 year old child had a seizure with loud breathing noises and excess saliva while sleeping. The duration of the seizure was approximately 3 minutes, and the child recovered by going back to sleep without waking up. The child has a history of a single seizure 1 year before this event.
after administration  of vaccine, patient felt hot and going to pass out, patient refused epinephrine injection and 911. patient waited around for about an hour after vaccination - patient BP went up, felt weak, signs of weakness, tongue big and throat closing - patient refused epinephrine again, called on call doctor who suggested Benadryl 25mg. Facility gave patient 25mg Benadryl  IM. Patient to be monitored at facility
Allergy reaction; tightness of chest; cough; dizziness; high blood pressure; over heated; This is a spontaneous report from a contactable consumer or other non hcp.     A 47-years-old female Non pregnant patient received bnt162b2 (BNT162B2 PFIZER BIOTECH COVID19 MRNA SOLUTION FOR INJECTION (Batch/Lot Number: FF8839), dose 1 via an unspecified route of administration, administered in Arm Left on 09Oct2021 11:00 (Batch/Lot Number: FF8839) as dose 1, single for covid-19 immunisation. Medical history included hypertension, asthma, sleep apnoea syndrome, hypersensitivity, multiple allergies to environmental and medication. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine, The patient received within 2 weeks of vaccination have Allergies so took Allergy shots week. It was reported that the patient experienced on 09Oct2021 11:15 Allergy reaction, tightness of chest, cough, dizziness, high blood pressure, over heated with outcome of recovered with sequelae. The patient underwent lab tests and procedures which included blood pressure measurement. Case was assessed as non-serious no prolonged hospitalization. Therapeutic measures were 50 mg benadryl. Ice pack. Olmersartan 40 25mg taken as a result of allergy reaction (hypersensitivity), tightness of chest (chest discomfort), cough (cough), dizziness (dizziness), high blood pressure (hypertension), over heated (feeling hot).  Follow-up (03Nov2021): Follow-up attempts are completed. No further information is expected.
Information had been received on 06-JUL-2017 from a lawyer regarding a case in litigation. It was alleged in litigation that a female patient of unknown age was inoculated with ZOSTAVAX vaccine (dose, route, site of administration, lot # and expiration date were not provided) on or about 03-JAN-2011 by a physician, as recommended for routine adult health maintenance and for the prevention of shingles. The patient's medical history, concurrent conditions and concomitant medication were not provided. The lawyer reported, the ZOSTAVAX vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of Herpes Zoster. On or about 17-JUN-2014, the patient was treated by a physician for a vesicular rash accompanied by symptoms of weakened immunity, which was diagnosed as severe Herpes Zoster, or shingles. The  patient was prescribed clotrimazole betamethasone cream for management of these painful symptoms. On or about 25-OCT-2015, the patient was treated by a physician at a Urgent Care facility for new and worsening symptoms of shingles outbreaks. The patient was then prescribed VALTREX and prednisone for her condition. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses and pain and suffering and other damages. Additional information has been requested.
I went to my doctor for a routine exam, they noticed my blood pressure was high. She checked it at the end of the exam, it was still high, she prescribed me medication to help bring it down. We have been watching my blood pressure and I have been following up with her every month and my blood pressure is currently back to normal.
April 10th, pain at injection site, headache, chills, sore throat, runny nose, coughing, muscle aches, and fatigue.
Vaccine was given to a patient that was not yet 18 (17 and 5 months at the time).  No issues report.
EDC 6/18/22  Received vaccine 2/17/22; On 2/18/22 began c/o migraine with nausea/vomiting lasting one day;  On 2/19/22 began c/o right shoulder pain radiating to the back lasting one week ;  Was followed by OB and PCP;
Facial paralysis, possible menigitis, severe headache and swollen joints.  Patient received prednisone and pain relievers from primary care doctor and is under her care.
The day after the vaccine, pt had a 5 inch by 3.5 inch erythematous, inflamed hot area around injection site. She also had a fever of which she took Advil.
Patient is a 59 y.o. female with past medical history significant for diabetes, smoking, asthma who presents to the emergency department with shortness of breath and diarrhea.  Constitutional: Positive for fatigue.  Respiratory: Positive for cough, chest tightness and shortness of breath.   Cardiovascular: Negative for chest pain and leg swelling.  Gastrointestinal: Positive for diarrhea. Negative for nausea and vomiting.   She was on 6L NC on admission, moved to HFNC on 1/17 night. Started on dex and Remdesivir on 1/16. She completed a course of remdesivir and received 8 doses of Dex 6mg PO QD.  Baricitinib was started on 1/18. She was on this from 1/18-1/23.  She also completed a course of azithromycin/ceftriaxone for suspected CAP. After starting the dexamethasone her glucose became uncontrolled. She spent some time on an insulin gtt but was weaned down and stable with Glargine 48u at bedtime and lispro 12 u QAC. After starting the baricitinib, she had marked improvement in her oxygenation. She was weaned down daily until she plateaued at 2L NC. She is able to perform her ADLs and ambulating in the room w/ O2. She is requesting to go home to care for her son who has COVID as well.  We will discharge her w/ home O2 and set her up with hospital at home. I will also refer her to pulmonary rehab.   Discharge Disposition/Condition Disposition: Home w/ hospital at home Condition: Stable (s/sx potential problems absent or manageable)
I have been sick since the day after the first the first Pfizer shot. 24 hour head ache, drowsy, lost concentration, ringing in my ears and just cant seem to wake up. I have been to the doctor three times and had mutable blood labs, and am now seeing a neurologist who has ordered a MRI of my brain. The problem is none of the doctors have any experience dealing with these adverse symptoms from the injection, does anybody? So who is going to help me before the lights go completely out?????
Initial information received on 14-Aug-2018 regarding an unsolicited valid non-serious case received from a consumer/non-hcp. This case involves 5 child patients who experienced hotness, swelling, soreness, large welts the size of baseball and redness, while he/she received vaccine QUADRACEL. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medication not reported. On an unknown date, the patient received a dose of suspect DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE lot number not reported. On an unknown date, The patient developed a non-serious redness, hotness, swelling, soreness (inflammation) following the administration of DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE. On an unknown date, The patient developed a non-serious large welts the size of baseball (urticaria) following the administration of DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE. Final diagnosis was large welts the size of baseball, redness, soreness, swelling and hotness. Lab test not reported. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Unknown for redness, soreness, swelling and hotness and as Unknown for large welts the size of baseball.
Chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHILLS (Chills) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03M20A??) for COVID-19 vaccination.     No reported medical history. .  Concomitant products included FAMOTIDINE and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Feb-2021, the patient experienced CHILLS (Chills). At the time of the report, CHILLS (Chills) had not resolved.            No treatment information was provided.   This case was linked to MOD-2021-032389 (Patient Link).
Pt. states that after receiving the 1st dose of J&J 08/14/2021, symptoms started 08/15/2021 02:00am experiencing body aches throughout the body, joints and shoulders with extreme, chills, feverish, sweating, nausea, dizziness, blurry vision, and extreme fatigue. Sharp chest pains running through the chest, subsided by 08/16/2021. Still experiencing symptoms. No noted Primary visit noted.
Pt states on Friday night 26JUL91 had nausea/vomiting, SOB, broke out in rash, went to ER was given Vistaril; ER MD stated should never have another TD injection;
It was a swollen lymph node at the base of my neck near my clavicle and it started out small but it grew about the size of a dime. You could almost see it. I decided to go to the doctor because it did not went away in a week, but it got smaller. He did not diagnosed anything but gave me Tylenol. It is gone now. I had my second shot in my second arm
pt states that after getting the covid vax she went back to work she started getting dizzy and her heart rate was up to 128.  Pt went to the school nurse where she works to be checked out.  Her BP was elevated and pulse rate was at 122.  She rested for a while and had her vitals checked again which was coming down.  Pt says once she gets her heart rate down to normal (84 )that if she even got up to walk it would go back up to 118.  She says if she gets it down back to normal and gets back up to walk it immediately goes back to around 105 or higher.  She went to her PCP and had an EKG and blood work which was normal.  Th e EKG was compared it to an old one but doctor did not find anything to be concerned about.  She is still experiencing these symptoms.  She took her Covid dose on March 12th and had the same exact symptoms as  she did after getting the first dose.  As of today she her heart rate still goes up with just getting up out of a chair and walking across the room.  She has another appt w/ her PCP today 3/23/2021.